Target intelligence / Profile preview

Arginine and serine rich coiled-coil 1 (RSRC1)

Target
RSRC1
Molecular classification
Other (splicing factor, non-snRNP protein)
01

Overview

Arginine and serine rich coiled-coil 1 (RSRC1) is a protein-coding gene that encodes a non-snRNP (small nuclear ribonucleoprotein) splicing factor involved in both constitutive and alternative pre-mRNA splicing, as well as transcription regulation[1][2][4][5][6]. RSRC1 is ubiquitously expressed and plays a pivotal role in RNA processing, especially the second step of splicing. Loss or mutation of RSRC1 impairs normal splicing and transcription, leading to effects on cell proliferation, migration, and neurodevelopment. RSRC1 acts as a tumor suppressor in gastric and possibly other cancers by influencing the PTEN/FAK signaling pathway, and its deficiency is associated with poor survival in gastric cancer and neurodevelopmental disorders such as intellectual disability and schizophrenia[1][2][3]. It does not act as a conventional drug target (such as a receptor, enzyme, transporter, or ion channel), and no drugs or direct therapeutic interventions are currently known to target RSRC1.

Other names
Serine/arginine-related protein 53SRrp53BM-011SFRS21Splicing factor, arginine/serine-rich 21MRT70MGC12197Arginine/serine-rich coiled-coil protein 1
02

Biological functions

Constitutive mRNA splicingAlternative mRNA splicing regulationTranscription regulation
03

Disease associations

Cancer (notably gastric cancer, glioblastoma, prostate cancer)Neurodevelopmental disorders (intellectual disability, schizophrenia, Alzheimer's disease, neuroblastoma)

Beyond the preview

Go deeper on Arginine and serine rich coiled-coil 1 (RSRC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginine and serine rich coiled-coil 1 (RSRC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call